Jpmorgan Chase & CO Glaukos Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Glaukos Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 234,282 shares of GKOS stock, worth $30.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
234,282
Previous 89,766
160.99%
Holding current value
$30.8 Million
Previous $8.46 Million
227.59%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GKOS
# of Institutions
310Shares Held
46.8MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$716 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$249 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$244 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$212 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.25B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...